2002
DOI: 10.1067/mpd.2002.120834
|View full text |Cite
|
Sign up to set email alerts
|

Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

8
186
1
7

Year Published

2002
2002
2009
2009

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 225 publications
(202 citation statements)
references
References 28 publications
8
186
1
7
Order By: Relevance
“…When comparing dopamine and dobutamine in the treatment of low SBF in 42 patients, 40% of patients did not respond at all, while dobutamine achieved better SBF increase and dopamine achieved BP increase in the others. 12 Dopamine was more effective than dobutamine in raising BP in 20 hypotensive infants however dopamine did not increase LVCO. 13 Both dopamine and dobutamine failed to increase myocardial contractility in 106 infants with low SBF in the first day of life, with dopamine increasing LV stress.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…When comparing dopamine and dobutamine in the treatment of low SBF in 42 patients, 40% of patients did not respond at all, while dobutamine achieved better SBF increase and dopamine achieved BP increase in the others. 12 Dopamine was more effective than dobutamine in raising BP in 20 hypotensive infants however dopamine did not increase LVCO. 13 Both dopamine and dobutamine failed to increase myocardial contractility in 106 infants with low SBF in the first day of life, with dopamine increasing LV stress.…”
Section: Discussionmentioning
confidence: 91%
“…Previous studies describing the pharmacological effects of dopamine, dobutamine, milrinone, epinephrine or hydrocortisone have not shown consistent changes in the LVCO and SV. [9][10][11][12][13][14][15][16] Hydrocortisone, 9 commonly used to increase BP in infants unresponsive to dopamine, failed to increase LVCO significantly in a study of 15 hypotensive infants. The hemodynamic effect of dopamine has been examined in several studies: A trend of increasing RVCO, did not reach statistical significance, with significant increase of the shortening fraction in 8 hypotensive premature infants; 10 in 50 hypotensive patients treated with dopamine, LVCO dropped in 40, compared to 10 others in whom LVCO increased 11: BP did increase in the low LVCO group, with concomitant increase in the SVR.…”
Section: Discussionmentioning
confidence: 99%
“…1 design to compare the effects of dopamine and dobutamine at 10 and 20 mcg/kg/min on SVC flow and blood pressure in VLBW neonates during the first postnatal day. 27 They found that dopamine improved systemic blood pressure more effectively at the two doses used, while dobutamine was better at increasing SVC flow at the two doses tested. As pharmacodynamics rather than pharmacokinetics determine the cardiovascular response to these sympathomimetic amines, a limitation of this study is the lack of a stepwise titration of these drugs in search for the optimal hemodynamic response.…”
Section: Introductionmentioning
confidence: 97%
“…bedside assessment of CBF using SVC flow measurements 7,27 and/or NIRS. 3,5,9,22 Management of this presentation of circulatory compromise is difficult and findings in the literature are somewhat contradictory.…”
Section: Introductionmentioning
confidence: 99%
“…1 In preterm infants, the complex physiology of the postnatal transition and the inherent immaturity of the cardiopulmonary and other organ systems present the most important challenge of establishing normative values, as continuous blood pressure monitoring in itself is insufficient to identify abnormal organ blood flow and tissue oxygen delivery in this patient population. 2 Furthermore, although there is an abundance of evidence showing improvement in blood pressure and other cardiovascular parameters, such as cardiac output, cerebral and non-vital organ blood flow and renal function, when 'hypotension' is treated during postnatal transition, [3][4][5][6][7][8][9][10] there are no data showing that treatment results in improvements in long-term outcome.…”
Section: Introductionmentioning
confidence: 99%